Jefferies Group’s Novavax NVAX Stock Holding History

Jefferies Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.54M	Sell	84,600 -43,400	-34%	-$1.88M	0.01%	686
2022 Q2	$6.58M	Buy	128,000 +118,000	+1,180%	+$6.11M	0.05%	283
2022 Q1	$737K	Buy	+10,000	New	+$892K	﹤0.01%	950
2021 Q3	–	Sell	-5,000	Closed	-$1.06M	–	1926
2021 Q2	$1.06M	Sell	5,000 -8,200	-62%	-$1.5M	0.01%	975
2021 Q1	$2.39M	Buy	+13,200	New	+$2.63M	0.02%	617
2020 Q3	–	Sell	-10,000	Closed	-$834	–	1484
2020 Q2	$834	Buy	+10,000	New	+$382K	0.01%	804
2019 Q2	–	Sell	-1,245	Closed	-$14K	–	2771
2019 Q1	$14K	Sell	1,245 -5	-0.4%	-$158	﹤0.01%	2255
2018 Q4	$46K	Buy	+1,250	New	+$48.4K	﹤0.01%	2029
2016 Q4	–	Sell	-6,010	Closed	-$250K	–	2388
2016 Q3	$250K	Buy	6,010 +5,620	+1,441%	+$726K	﹤0.01%	1867
2016 Q2	$57K	Buy	+390	New	+$44.7K	﹤0.01%	1985

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jefferies Group's NVAX Position: Q3 2022 in Review

Jefferies Group opened a new position in Novavax (NVAX) in Q3 2022: 70 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #1594 among its holdings. This is a return to the name: Jefferies Group previously reported a position in NVAX as recently as Q1 2022.

Jefferies Group first reported a position in NVAX in Q3 2015 and has held it in 15 quarters since. The position peaked at $3.9M in Q4 2020. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

Jefferies Group held 70 shares of Novavax worth $1.27K as of Q3 2022.
Novavax was a new Jefferies Group position in Q3 2022.
Novavax made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1594 holding.
Jefferies Group first reported a position in Novavax in Q3 2015 and has held it in 15 quarters since.
Jefferies Group's Novavax position peaked at $3.9M in Q4 2020.
253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.